Notice on Convening the 2024 Annual General Meeting
Filed with SSE · · 9 pages · Chinese
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhangzhou Pientzehuang Pharmaceutical
- Announcement on Attending the Online Collective Reception Day for Investors of Listed Companies in Fujian Jurisdiction in 2025 and the 2024 Annual and Q1 2025 Performance Briefing
- Announcement on Daily Related Party Transactions in 2024 and Estimated Daily Related Party Transactions in 2025
- Announcement on Resolutions of the 19th Meeting of the 7th Board of Supervisors
- Announcement on Receiving Notice of Approval for Drug Clinical Trials
- Announcement on 2024 Annual Preliminary Earnings Estimate
Later from Zhangzhou Pientzehuang Pharmaceutical
- Announcement on Progress of Investment and Participation in Zhaoying Huikang Fund
- Announcement on Resolution of the General Meeting
- Indicative Announcement on Free Transfer of State-owned Shares and Equity Change Reaching 1% for Shareholders with Over 5% Shares
- Announcement on Completing Registration of Free Transfer of State-owned Shares
- Announcement on Implementation of Dividend Distribution for 2024
Follow Zhangzhou Pientzehuang Pharmaceutical into a list and get an email when it puts out news.
Follow Zhangzhou Pientzehuang Pharmaceutical